Latest news
Kymera Therapeutics (KYMR) Could Be 23% Undervalued On Its New CMO Appointment - simplywall.stsimplywall.st · Sun, 02 Aug 2026 02:16:19 GMTKymera Therapeutics to Report Q2 2026 Results on Aug 5 - scanx.tradescanx.trade · Tue, 28 Jul 2026 07:00:00 GMTCMO appointment steadies Kymera Therapeutics stock amid mild pullback - Traders UnionTraders Union · Tue, 28 Jul 2026 05:07:16 GMT